Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Pharmacological profile of broad-spectrum, nonopioid analgesic described by Abbott

Jan. 21, 1998

Controlled-release tramadol under development

Jan. 20, 1998

Zeneca commits to development of Zomig line extensions

Jan. 20, 1998

Novel atypical antipsychotic agent presented by Lundbeck

Jan. 20, 1998

MS&D reveals new class of antimigraine agents

Jan. 20, 1998

Preclinical and clinical studies presented for RS-8359

Jan. 19, 1998

Alza and Janssen E-TRANS pain product collaboration unveiled

Jan. 19, 1998

Novel CNS agents disclosed by HMR

Jan. 19, 1998

More dopaminergic agents in the pipeline at Neurogen

Jan. 19, 1998

New therapeutic tetrahydrofuran derivatives from Janssen

Jan. 19, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 28, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
Daybu readthrough in EU? Zevra’s NPC bid flounders
BioWorld
Zevra Therapeutics Inc. will try to follow in the footsteps of Acadia Pharmaceuticals Inc. with Rett syndrome drug Daybu (trofinetide) by asking the EMA’s...
Regulatory actions for July 27, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Alfasigma,...